MAXWEALTH FUNDMAXWEALTH FUNDMAXWEALTH FUND

MAXWEALTH FUND

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪2.99 B‬CNY
Fund flows (1Y)
‪1.10 B‬CNY
Dividend yield (indicated)
Discount/Premium to NAV
0.2%
Shares outstanding
‪5.72 B‬
Expense ratio
0.60%

About MAXWEALTH FUND


Issuer
Maxwealth Fund Management Co., Ltd.
Brand
Maxwealth
Inception date
Apr 22, 2021
Structure
Open-Ended Fund
Index tracked
CSI All-Medical Device Index - CNY - Benchmark TR Gross
Replication method
Physical
Management style
Passive
Dividend treatment
Distributes
Primary advisor
Maxwealth Fund Management Co., Ltd.
ISIN
CNE100004HK1
Tightly track the index performance of the target, and pursue the minimization of tracking deviation and tracking err.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Broad-based
Strategy
Vanilla
Geography
China
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of December 31, 2024
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.42%
Health Technology83.04%
Process Industries7.35%
Health Services2.32%
Distribution Services1.95%
Producer Manufacturing1.66%
Commercial Services1.52%
Electronic Technology1.07%
Industrial Services0.28%
Consumer Non-Durables0.23%
Bonds, Cash & Other0.58%
Cash0.35%
Corporate0.23%
Stock breakdown by region
100%
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


159883 invests in stocks. The fund's major sectors are Health Technology, with 83.04% stocks, and Process Industries, with 7.35% of the basket. The assets are mostly located in the Asia region.
159883 top holdings are Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A and Shanghai United Imaging Healthcare Co., Ltd. Class A, occupying 15.62% and 7.96% of the portfolio correspondingly.
159883 assets under management is ‪2.99 B‬ CNY. It's risen 62.33% over the last month.
159883 fund flows account for ‪1.10 B‬ CNY (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 159883 doesn't pay dividends to its holders.
159883 shares are issued by Maxwealth Fund Management Co., Ltd. under the brand Maxwealth. The ETF was launched on Apr 22, 2021, and its management style is Passive.
159883 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
159883 follows the CSI All-Medical Device Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
159883 invests in stocks.
159883 price has risen by 6.80% over the last month, and its yearly performance shows a 12.61% increase. See more dynamics on 159883 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 7.62% over the last month, showed a 12.34% increase in three-month performance and has increased by 18.00% in a year.
159883 trades at a premium (0.15%) meaning the ETF is trading at a higher price than the calculated NAV.